-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(Health Times reporter Mao Yuanyuan) "The anticancer drug K in the lung cancer field has succeeded, but the O drug has failed.
Clinical research is a key link in the pharmaceutical innovation industry.
"When drugs are developed globally, in accordance with the guidelines of ICH (International Conference for Harmonization) E5, in the early stages of development, studies are needed to assess whether drugs are ethnically sensitive.
Clinical trials are the only way to verify the safety and effectiveness of drugs in the human body.
Therefore, it is very necessary to carry out more disease research in China, and real-world research is an important means and method.
It is reported that at this conference, Jiang Min, director of the Office of National Drug Clinical Trial Institutions of Peking University Cancer Hospital, Xu Jiming, co-founder of Yidu Technology Group and CEO of Happy Life Technology, and Wang Tongyan, general manager of DIA China, jointly launched the "Clinical Trials and Research The Institutional Digital Innovation Collaboration Initiative" aims to promote the application of digital technology in clinical research, improve research efficiency and quality, promote the digital construction of research institutions, and coordinate the communication between the clinical research industry and supervision.
